PHILHAVEN — History
CCN 394020 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$73M
Latest Revenue (FY2022)
+12.4%
Revenue CAGR (3yr)
-32.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $58M | $59M | $73M | +24.8% | +12.4% |
| Operating Expenses | $87M | $92M | $97M | +5.0% | +5.3% |
| Operating Margin | -50.3% | -56.9% | -32.1% | +43.7% | +0.0% |
| Net Income | $-29M | $-33M | $-23M | +29.7% | +0.0% |
| Licensed Beds | 118 | 118 | 118 | +0.0% | +0.0% |
| Total Patient Days | 42,154 | 41,489 | 41,694 | +0.5% | -0.5% |
| Medicare Day % | 3% | 3% | 2% | -20.6% | -9.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +26.3% ($58M → $73M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.4%
This Hospital
+7.6%
State Avg
Latest Margin
-32.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $81M | -23.0% |
| FY2024 (proj) | $88M | -13.9% |
| FY2025 (proj) | $96M | -4.7% |